SERPINF1 and metabolic dysfunction-associated steatohepatitis: Studies have shown that PEDF has anti-oxidative capacities and protects hepatocytes from inflammation-induced cell death during NASH progression [14,16], suggesting that PEDF is an important hepatokine beyond merely being a lipolytic agent.